Health & Science
Tau-Targeting Alzheimer's Drug Shows Promise in Trial
Biogen's diranersen targeting tau protein shows cognitive benefits in Phase 2 Alzheimer's trial, offering a new pathway beyond amyloid.
—4 min read
Tag
#Clinical Trial
2 articles
HealthMedical Breakthrough
Experimental Pill Nearly Doubles Pancreatic Cancer Survival
A new experimental pill nearly doubles survival for advanced pancreatic cancer patients, targeting the long-undruggable KRAS mutation.
—5 min read